Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

fontus health ltd - galantamine hydrobromide - modified-release capsule - 24mg

Австралия - английски - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - galantamine hydrobromide, quantity: 30.768 mg - capsule, modified release - excipient ingredients: hydrogenated vegetable oil; povidone; magnesium stearate; colloidal anhydrous silica; sodium lauryl sulfate; polyvinyl acetate; titanium dioxide; allura red ac; potable water; gelatin; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - galantyl is indicated for the treatment of mild to moderately severe dementia of the alzheimer type.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - galantamine hydrobromide, quantity: 20.512 mg - capsule, modified release - excipient ingredients: povidone; magnesium stearate; hydrogenated vegetable oil; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; titanium dioxide; allura red ac; potable water; gelatin; sodium lauryl sulfate; colloidal anhydrous silica; polyvinyl acetate - galantyl is indicated for the treatment of mild to moderately severe dementia of the alzheimer type.

САЩ - английски - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - galantamine hydrobromide (unii: mj4ptd2vvw) (galantamine - unii:0d3q044kca) - galantamine 4 mg - galantamine tablets are indicated for the treatment of mild to moderate dementia of the alzheimer’s type. galantamine tablets are contraindicated in patients with known hypersensitivity to galantamine hydrobromide or to any excipients used in the formulation. there are no adequate and well-controlled studies in pregnant women. in studies conducted in animals, administration of galantamine during pregnancy resulted in developmental toxicity (increased incidence of morphological abnormalities and decreased growth in offspring) at doses similar to or greater than those used clinically. galantamine tablets should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. in rats, administration of galantamine (oral doses of 2 mg/kg/day, 8 mg/kg/day, or 16 mg/kg/day), from day 14 (females) or day 60 (males) prior to mating and continuing in females through the period of organogenesis, resulted in an increased incidence of fetal skeletal variations at the two highest doses. th

САЩ - английски - NLM (National Library of Medicine)

mylan institutional inc. - galantamine hydrobromide (unii: mj4ptd2vvw) (galantamine - unii:0d3q044kca) - galantamine 4 mg - galantamine tablets are indicated for the treatment of mild to moderate dementia of the alzheimer’s type. galantamine tablets are contraindicated in patients with known hypersensitivity to galantamine hydrobromide or to any excipients used in the formulation. there are no adequate and well-controlled studies in pregnant women. in studies conducted in animals, administration of galantamine during pregnancy resulted in developmental toxicity (increased incidence of morphological abnormalities and decreased growth in offspring) at doses similar to or greater than those used clinically. galantamine tablets should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. in rats, administration of galantamine (oral doses of 2 mg/kg/day, 8 mg/kg/day, or 16 mg/kg/day), from day 14 (females) or day 60 (males) prior to mating and continuing in females through the period of organogenesis, resulted in an increased incidence of fetal skeletal variations at the two highest doses. th

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr reddy's laboratories (uk) ltd - galantamine hydrobromide - modified-release capsule - 8mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr reddy's laboratories (uk) ltd - galantamine hydrobromide - modified-release capsule - 16mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr reddy's laboratories (uk) ltd - galantamine hydrobromide - modified-release capsule - 24mg

Малайзия - английски - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

johnson & johnson sdn bhd - galantamine hydrobromide -

Малайзия - английски - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

johnson & johnson sdn bhd - galantamine hydrobromide -